The FDA warned that patients taking higher than recommended doses of loperamide (Imodium) may experience serious heart problems, abnormal heart rhythms and death.

DUBLIN and NEW ORLEANS - June 10, 2016 - Delivering on its vision to transform care for the millions currently living with diabetes through intelligent data, Medtronic plc (NYSE:MDT) announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions that will create meaningful insights for providers and people with diabetes. 

(PresseBox) BIOTRONIK Home Monitoring® received strong endorsements during the Cardiostim scientific session “Improving Patient Outcomes in Arrhythmia Management.” 

On June 8, Nokia Technologies introduced the Withings Body Cardio, a wireless scale that measures a person’s weight, body mass index, body composition and standing heart rate.

A study from Texas A&M University is examining the use of high-resolution CT scans, virtual reality, vascular robotics systems and 3D printing to create personalized medicine, 3D Printing Industry reports. The researchers are aiming to analyze diagnostic data and tailor treatments to individuals to save money and improve care.

Boston Scientific plans on undergoing a restructuring program that will reduce the company’s gross annual pre-tax operating expenses by approximately $115 million to $150 million by the end of 2020, according to a company news release.

Patients with hypercholesterolemia who received an oral investigational medication (CAT-2054) and statin therapy did not have a reduction in low-density lipoprotein (LDL) cholesterol, which was the primary endpoint in the phase 2a trial.

Horizon Blue Cross Blue Shield of New Jersey and Trinitas Regional Medical Center announced they had formed a partnership and plan on launching a value-based care program to treat patients with heart failure.